WallStSmart
PLRX

Pliant Therapeutics Inc

NASDAQ: PLRX · HEALTHCARE · BIOTECHNOLOGY

$1.21
+0.00% today

Updated 2026-04-29

Market cap
$74.92M
P/E ratio
P/S ratio
3,071.82x
EPS (TTM)
$-2.43
Dividend yield
52W range
$1 – $2
Volume
0.6M

Pliant Therapeutics Inc (PLRX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$57.05M$41.82M$7.57M$9.69M$1.58M$0.00$0.00
Revenue growth (YoY)-26.7%-81.9%+27.9%-83.7%-100.0%
Cost of revenue$666000.00$3.20M$3.68M$1.84M$2.13M$1.70M
Gross profit$-666000.00$57.05M$41.82M$7.57M$9.69M$1.58M$-2.13M$-1.70M
Gross margin100.0%100.0%100.0%100.0%100.0%
R&D$14.53M$24.41M$47.35M$66.19M$77.55M$96.94M$127.80M$169.31M$109.16M
SG&A$3.82M$6.50M$10.93M$17.27M$27.56M$39.95M$57.93M$59.05M$47.22M
Operating income$-18.35M$-30.91M$-1.23M$-41.65M$-19.99M$-127.20M$-184.15M$-228.37M$-150.07M
Operating margin-2.2%-99.6%-263.9%-1313.4%-11654.7%
EBITDA$-18.06M$-30.25M$-118000.00$-40.34M$-18.45M$-118.85M$-158.23M$-205.16M$-148.38M
EBITDA margin-0.2%-96.5%-243.7%-1227.1%-10014.4%
EBIT$-18.35M$-30.91M$-1.23M$-41.65M$-19.99M$-122.53M$-160.07M$-207.28M$-150.07M
Interest expense$0.00$0.00$216000.00$366000.00$272000.00$791000.00$1.27M$3.02M$2.56M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-20.62M$-30.28M$-631000.00$-39.74M$-17.91M$-123.32M$-161.34M$-210.30M$-149.34M
Net income growth (YoY)-46.8%+97.9%-6198.7%+54.9%-588.7%-30.8%-30.4%+29.0%
Profit margin-1.1%-95.0%-236.5%-1273.3%-10211.1%